Skip to main content
OpenTrials
Completed

NCT Number: NCT05209204

Anterior Chamber Angle Examination in Angle Closure Suspect Patients

The aim of this study is to detect PACG suspects using both AS OCT and Scheimpflug imaging.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Minia University hospital

Minya, Egypt

About this study

Glaucoma is a form of progressive optic neuropathy and is one of the leading causes of preventable blindness worldwide. The average life span is increasing leading to more individuals developing glaucoma as well as having the disease longer, which makes early detection and management very important.[1] Glaucoma is characterized by loss of retinal ganglion cells (RGCs) recognized as optic nerve head (ONH) changes, corresponding visual field (VF) defects and retinal nerve fiber layer (RNFL) loss. At least 40% of RGCs are lost before the VFs show a defect, hence the emphasis on early diagnosis in the stage of glaucoma suspect.[2] There are two types of glaucoma suspect: Primary Open angle and primary angle closure suspect.(3) Primary angle-closure (PAC) suspects can be detected by the following: the trabecular meshwork can only be seen in 180º or less of anterior chamber angle (AC) by gonioscopy, the intraocular pressure(IOP) remains within normal limits and no structural damage to the optic nerve is present.[4] Time domain Optical coherence tomography (TD-OCT) was initially designed to image the posterior segment and retina, but its capability to generate cross-sectional images of internal biological structures without contacting the ocular surface was quickly adapted to visualize the anterior segment and cornea.[5].

Spectral domain anterior segment OCT (SD-OCT) technology allow visualizing the anterior chamber angle of the eye with high speed and high resolution. Spectral-domain OCT(SD OCT) instruments working at 840 nm can reliably identify fine angle structures such as Schwalbe's line.(6) Scheimpflug imaging also offers non-contact imaging of the anterior segment. Although Scheimpflug photography cannot fully visualize the entire angle, the software available on the Pentacam system (Oculus Optikgeräte, Wetzlar, Germany) provides extrapolated measurements of the anterior chamber volume (ACV), which have shown promise in screening for narrow angles.(7)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Hyperopes. 2-Shallow AC. 3-With gonioscopy carried out under dim-light conditions without indentation ,with the eye in primary position there is inability to visualize ≤ 180° of the posterior trabecular meshwork (TM) in the absence of peripheral anterior 4-IOP ≤ 21 as measured by tonometry. 5-Normal visual field on static automated perimetry (SAP) testing. 5-Normal optic nerve head (ONH) appearance on fundus biomicroscopy. 6-Family history of primary angle closure disease.

Exclusion criteria

  • 1-Eyes with significant corneal opacity that can impare signal strings of any of the used imaging modalities.

2-Eyes wih history of intraocular surgery (e.g. cataract surgery ,retinal detachment surgery).

3-Eyes with history of laser procedures (e.g.laser peripheral iridotomy). 4-Eyes with anterior segment pathology as iridocyclitis or angle disgenesis 5. Eyes with history of trauma. 6- Eyes with findings suggestive of 2dry cause of glaucoma (e.g. iris or angle neovascularization, any iris or corneal abnormalities, dilated episcleral vessels ).

Treatment and study plan

ASOCT

Diagnostic Test

Anterior segment imaging using RTVue XR 100 Avanti OCT platform (Optovue Inc.,Fairmont, CA).

Pentacam

Diagnostic Test

Anterior segment imaging using Oculus Pentacam HR (Oculus Optikgeräte, Wetzlar, Germany).

Primary outcomes

  1. Anterior segment parameters as measured by AS-OCT:

    Time frame: 3 months

    Anterior chamber depth (ACD)..

  2. Anterior segment parameters as measured by Oculus Pentacam:

    Time frame: 3 months

    Anterior chamber angle (ACA).

  3. Anterior segment parameters by ASOCT

    Time frame: 3 months

    Angle opening distance at 750 µm (AOD750).

  4. Anterior segment parameters by OCT

    Time frame: 3 months

    Anterior chamber angle (ACA).

  5. Pentacam parameters

    Time frame: 3 months

    Anterior chamber volume (ACV).

  6. Pentacam parameters by Oculus Pentacam:

    Time frame: 3 months

    Anterior chamber depth (ACD).

Sponsors and collaborators

Lead sponsor

Minia University

Other

Registry information

Important dates

Study start
2019
Primary completion
2019
Study completion
2020
First posted
Jan 26, 2022
Registry last updated
Jan 26, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.